Having watched as the doctors balanced the morphine dosage for my mother as she died of colon cancer, you can count me as one who is very enthusiastic about the prospect of improved cancer therapies, for obvious reasons. Now--H/T Vox Populi--comes a report from Amgen that of 53 pioneering studies about cancer, 47 could not be replicated.
Now to be fair, these are studies, not clinical trials for the FDA (where at least two consecutive studies are required before a drug can be approved), but it is still sobering to read. If one is doing statistically based work, 95% confidence ought to be required, and hence if a large portion of these studies are not reproducible, what it means is that either (a) scientists are choosing a standard of statistical significance that is so low as to be meaningless or (and/or) (b) scientists are putting their fingers on the scales. Either one ought to be very sobering to us.
The Great Gold Rotation - "300 tons" - Gold ETFs Are Liquidating By the Ton Excerpt: An ounce of gold, often represented by a single American Eagle coin, is a fairly easy thing to visualize...
1 hour ago